Measuring energy expenditure in narcolepsy using doubly labeled water and respiration chamber calorimetry

Claire E.H.M. Donjacour (Corresponding author), Jari K. Gool, Paul F. Schoffelen, Loek Wouters, Sebastiaan Overeem, Gert Jan Lammers, Hanno Pijl, Klaas R. Westerterp

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)

Abstract

STUDY OBJECTIVES: Hypocretin deficiency causes type 1 narcolepsy, a condition characterized by excessive daytime sleepiness, cataplexy, and fragmented nocturnal sleep. Two-thirds of people with narcolepsy are also overweight, of which half are obese. The pathophysiology behind weight gain in people with narcolepsy remains unknown. We assessed a possible decrease in energy expenditure as a cause for overweight in narcolepsy using respiration chamber calorimetry and doubly labeled water.

METHODS: Ten males with type I narcolepsy and nine matched (for age, sex, and BMI) healthy controls were enrolled. Participants stayed in a respiration chamber for 24 hours. They subsequently received doubly labeled water and wore an accelerometer for 2 weeks to assess energy expenditure and physical activity under daily living conditions. Total daily energy expenditure, resting energy expenditure (REE), overnight metabolic rate, physical activity level, and activity-induced energy expenditure were measured.

RESULTS: No significant differences were found in REE, mean 24-hour respiration chamber energy expenditure, overnight metabolic rate, and activity-induced energy expenditure when comparing people with narcolepsy type 1 to controls. Physical activity was also comparable between groups.

CONCLUSIONS: Energy expenditure in narcolepsy type 1 is similar to matched controls, suggesting comparable metabolism and physical activity rates. It remains possible that metabolic changes are most pronounced around disease onset. In addition, patients had to discontinue their medication which may have influenced the results. Still, our findings suggest that other factors may also play a role in weight gain in narcolepsy, such as differences in dietary behavior.

Original languageEnglish
Article numberzsae263
JournalSleep
Volume48
Issue number4
Early online date15 Nov 2024
DOIs
Publication statusPublished - Apr 2025

Funding

UCB Pharma Brussels has funded this study. UCB has not been involved in the study design, execution, interpretation of results, or the decision to publish. The work was performed at the Department of Human Biology, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands. We would like to thank all people with narcolepsy and healthy volunteers participating in the project. In addition thanks to Ley Sander for editing the manuscript. SO consulted for Bioprojet, Jazz Pharmaceuticals, and Takeda, all paid to the institution and not related to present work. GJL consulted for Bioprojet, Jazz Pharmaceuticals, UCB Pharma, NLS, and Takeda, all paid to the institution and not related to the present work. He also served as member of advisory boards on narcolepsy: Bioprojet, Jazz Pharmaceuticals, UCB Pharma, NLS. The other authors have indicated no potential financial conflicts of interest. Nonfinancial disclosure: none. Preprint repository: none.

Keywords

  • Humans
  • Male
  • Energy Metabolism/physiology
  • Narcolepsy/metabolism
  • Adult
  • Calorimetry/methods
  • Basal Metabolism/physiology
  • Accelerometry
  • Calorimetry, Indirect
  • Motor Activity/physiology
  • accelerometer
  • hypocretin
  • metabolism
  • orexin
  • overweight

Fingerprint

Dive into the research topics of 'Measuring energy expenditure in narcolepsy using doubly labeled water and respiration chamber calorimetry'. Together they form a unique fingerprint.

Cite this